Search research articles
Contact Us
Filters
Showing results (21-30 of 31) with videos related to
Page
of 4
Sort By:
Intensive Care Medicine
|
January 1, 1991
Myxoedema coma: response of thyroid hormones with oral and intravenous high-dose L-thyroxine treatment
S Arlot, X Debussche, J D Lalau, et al.
Presse Medicale (Paris, France : 1983)
|
March 7, 1987
[Creatinine clearance in the elderly. Comparison of results obtained by different methods of evaluation]
X Debussche, J D Lalau, P Doublet, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux
|
April 27, 2004
[Prevention of recurrent amiodarone-induced hyperthyroidism by iodine-131]
J S Hermida, G Jarry, E Tcheng, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|
November 1, 1988
Plasma renin activity and aldosterone in untreated hypothyroidism
S Arlot, A Mesmacque, J D Lalau, et al.
Archives Francaises De Pediatrie
|
August 1, 1985
[Male pseudohermaphroditism caused by partial insensitivity to androgens. Clinical and biochemical heterogeneity]
C Sultan, A Terraza, A Chabab, et al.
Presse Medicale (Paris, France : 1983)
|
April 7, 1984
[Insulinomas: pre- or intraoperative diagnosis of localization]
J D Lalau, P Verhaeghe, V Moullart, et al.
Annales D'Endocrinologie
|
January 1, 1985
[Insulinoma: critical study of methods of localization and strategy]
J D Lalau, P Verhaeghe, V Moullart, et al.
The Journal of Clinical Endocrinology and Metabolism
|
June 9, 2001
Efficacy of the long-acting octreotide formulation (octreotide-LAR) in patients with thyrotropin-secreting pituitary adenomas
P Caron, S Arlot, C Bauters, et al.
The Journal of Clinical Endocrinology and Metabolism
|
April 19, 2000
Evaluation of the treatment of thyrotropin-secreting pituitary adenomas with a slow release formulation of the somatostatin analog lanreotide
J M Kuhn, S Arlot, H Lefebvre, et al.
Annales D'Endocrinologie
|
August 12, 2003
[Pilot study and preliminary validation of the French version of a quality-of-life questionnaire specific for subjects with growth hormone deficiency]
A Leplège, E Ecosse, F Archambau, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 31) with videos related to
Sort By:
Page
of 4
Intensive Care Medicine
|
January 1, 1991
Myxoedema coma: response of thyroid hormones with oral and intravenous high-dose L-thyroxine treatment
S Arlot, X Debussche, J D Lalau, et al.
Presse Medicale (Paris, France : 1983)
|
March 7, 1987
[Creatinine clearance in the elderly. Comparison of results obtained by different methods of evaluation]
X Debussche, J D Lalau, P Doublet, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux
|
April 27, 2004
[Prevention of recurrent amiodarone-induced hyperthyroidism by iodine-131]
J S Hermida, G Jarry, E Tcheng, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|
November 1, 1988
Plasma renin activity and aldosterone in untreated hypothyroidism
S Arlot, A Mesmacque, J D Lalau, et al.
Archives Francaises De Pediatrie
|
August 1, 1985
[Male pseudohermaphroditism caused by partial insensitivity to androgens. Clinical and biochemical heterogeneity]
C Sultan, A Terraza, A Chabab, et al.
Presse Medicale (Paris, France : 1983)
|
April 7, 1984
[Insulinomas: pre- or intraoperative diagnosis of localization]
J D Lalau, P Verhaeghe, V Moullart, et al.
Annales D'Endocrinologie
|
January 1, 1985
[Insulinoma: critical study of methods of localization and strategy]
J D Lalau, P Verhaeghe, V Moullart, et al.
The Journal of Clinical Endocrinology and Metabolism
|
June 9, 2001
Efficacy of the long-acting octreotide formulation (octreotide-LAR) in patients with thyrotropin-secreting pituitary adenomas
P Caron, S Arlot, C Bauters, et al.
The Journal of Clinical Endocrinology and Metabolism
|
April 19, 2000
Evaluation of the treatment of thyrotropin-secreting pituitary adenomas with a slow release formulation of the somatostatin analog lanreotide
J M Kuhn, S Arlot, H Lefebvre, et al.
Annales D'Endocrinologie
|
August 12, 2003
[Pilot study and preliminary validation of the French version of a quality-of-life questionnaire specific for subjects with growth hormone deficiency]
A Leplège, E Ecosse, F Archambau, et al.
Page
of 4